Literature DB >> 4214839

Comparative activity of ampicillin and seven cephalosporins against group D streptococci.

J M Hamilton-Miller.   

Abstract

Minimum inhibitory concentrations have been determined for ampicillin and seven cephalosporins against 93 strains of group D streptococci isolated recently from clinical material. Ampicillin was much the most active compound (modal MIC = 1.6 mug/ml); cephaloridine, cephacetrile, and cefazolin had a modal MIC of 25 mug/ml, while corresponding figures for cephalothin, cephradine, cephalexin, and cefoxitin were 50, 100, 200, and 800 mug/ml, respectively. Thus, none of the newer cephalosporins is an improvement in respect to activity against enterococci over existing compounds, and ampicillin remains overwhelmingly the beta-lactam antibiotic of choice for the treatment of infections by such organisms. Pharmacokinetic considerations, however, indicate that certain cephalosporins, for instance, cephaloridine, cefazolin, and cephanone, may be worthy of further study in view of possible synergy with aminoglycoside antibiotics.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4214839      PMCID: PMC475493          DOI: 10.1136/jcp.27.10.828

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

Review 1.  Cephradine--a summary of preclinical studies and clinical pharmacology.

Authors:  E S Neiss
Journal:  J Ir Med Assoc       Date:  1973-03-24

2.  Cephapirin: pharmacology in normal human volunteers.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  J Clin Pharmacol New Drugs       Date:  1972 Feb-Mar

3.  Clinical laboratory study of cephacetrile and cephalothin against bacteria recently isolated from clinical specimens.

Authors:  H D Isenberg; B G Painter; J Sampson-Scherer; M Siegel
Journal:  Am J Clin Pathol       Date:  1973-05       Impact factor: 2.493

4.  Antimicrobial susceptibility of group D hemolytic streptococci (enterococci).

Authors:  H J Simon
Journal:  Am J Med Sci       Date:  1967-01       Impact factor: 2.378

5.  Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.

Authors:  P Toala; A McDonald; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

6.  Antibiotic synergism of enterococci. Relation to inhibitory concentrations.

Authors:  H D Standiford; J B De Maine; W M Kirby
Journal:  Arch Intern Med       Date:  1970-08

7.  New cephalosporin antibiotic--cephaloridine. Clinical and laboratory evaluation.

Authors:  M Turck; D W Belcher; A Ronald; R H Smith; J F Wallace
Journal:  Arch Intern Med       Date:  1967-01

8.  Cephapirin: in vitro antibacterial spectrum.

Authors:  J Axelrod; B R Meyers; S Z Hirschman
Journal:  Appl Microbiol       Date:  1971-11

9.  Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.

Authors:  J Kosmidis; J M Hamilton-Miller; J N Gilchrist; D W Kerry; W Brumfitt
Journal:  Br Med J       Date:  1973-12-15

10.  Presumptive identification of group D streptococci: the bile-esculin test.

Authors:  R R Facklam; M D Moody
Journal:  Appl Microbiol       Date:  1970-08
View more
  5 in total

1.  Penetration of cefazolin, ceftriaxone, cefoperazone, and ceftazidime into human gallbladder tissue and bile.

Authors:  S A Berger; Y Levy; A Halevy; A Gorea; R Orda
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

2.  Differential methotrexate sensitivity: a test to distinguish Enterococcus faecalis from Enterococcus faecium.

Authors:  J M Hamilton-Miller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

Review 3.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Cephamycins: a review, prospects and some original observations.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1975       Impact factor: 3.553

5.  Thymidylate Limitation Potentiates Cephalosporin Activity toward Enterococci via an Exopolysaccharide-Based Mechanism.

Authors:  Jessica S Hoff; Christopher J Kristich
Journal:  ACS Chem Biol       Date:  2016-03-23       Impact factor: 5.100

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.